Oncology research in Saudi Arabia over a 10-year period

References

1. ↵
   1. Cancer Care Ontario

   Ontario Cancer Management Guidelines, Available from: https://www.cancercareontario.ca/en/guidelines-advice. [Accessed 2019 November 25].
2. British Columbia Cancer Management Guidelines, Available from: http://www.bccancer.bc.ca/health-professionals/clinical-resources/cancer-management-guidelines. [Accessed 2019 November 25].
3. ↵
   National Comprehensive Cancer Network, Available from: https://www.nccn.org. [Update:Accessed 2019 November 25].
4. ↵
   1. Jazieh AR,
   2. Al Kattan K,
   3. Bamousa A,
   4. Al Olayan A,
   5. Abdelwarith A,
   6. Ansari J,
   7. et al.

   (2017) Saudi lung cancer management guidelines 2017. Ann Thorac Med 12:221–246.

   OpenUrl
5. ↵
   1. Alghamdi A,
   2. Alkhateeb S,
   3. Alghamdi K,
   4. Bazarbashi S,
   5. Murshid E,
   6. Alotaibi M,
   7. et al.

   (2016) Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for renal cell carcinoma. Urol Ann 8:136–140.

   OpenUrl
6. ↵
   1. Choi E,
   2. Lee S,
   3. Nhung BC,
   4. Suh M,
   5. Park B,
   6. Jun JK,
   7. et al.

   (2017) Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries. Epidemiol Health 39:e2017006.

   OpenUrl
7. 1. Fitzmaurice C,
   2. Akinyemiju TF,
   3. Al Lami FH,
   4. Alam T,
   5. Alizadeh-Navaei R,
   6. Allen C,
   7. et al.

   (2018) Global, Regional, and National Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 Cancer Groups 1990 to 2016:A systematic analysis for the global burden of disease study. JAMA Oncol 4:1553–1568.

   OpenUrl
8. 1. Fitzmaurice C,
   2. Allen C,
   3. Barber RM,
   4. Barregard L,
   5. Bhutta ZA,
   6. Brenner H,
   7. et al.

   (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups 1990 to 2015:A systematic analysis for the global burden of disease study. JAMA Oncol 3:524–548.

   OpenUrl
9. ↵
   1. Althubiti MA,
   2. Nour Eldein MM

   (2018) Trends in the incidence and mortality of cancer in Saudi Arabia. Saudi Med J 39:1259–1262.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Centre for Evidence-Based Medicine

    OCEBM Levels of Evidence, Available from: https://www.cebm.net/2016/05/ocebm-levels-of-evidence/. [Update 2016 May 1;Accessed 2019 November 25].
11. ↵
    1. Jamjoom BA,
    2. Jamjoom AA,
    3. Jamjoom AB

    (2014) Level of evidence of clinical neurosurgery research in Saudi Arabia. Neurosciences (Riyadh) 19:334–337.

    OpenUrl
12. ↵
    1. Makhdom AM,
    2. Alqahtani SM,
    3. Alsheikh KA,
    4. Samargandi OA,
    5. Saran N

    (2013) Level of evidence of clinical orthopedic surgery research in Saudi Arabia. Saudi Med J 34:395–400.

    OpenUrl
13. ↵
    1. Samargandi OA,
    2. Makhdom AM,
    3. Kaur M,
    4. Awan BA,
    5. Thoma A

    (2013) Level of evidence of plastic surgery clinical research in Saudi Arabia. Saudi Med J 34:1197–118.

    OpenUrl
14. ↵
    1. Maghrabi Y,
    2. Baeesa M,
    3. Kattan J,
    4. Altaf A,
    5. Baeesa SS

    (2017) Level of evidence of abdominal surgery clinical research in Saudi Arabia. Saudi Med J 38:788–793.

    OpenUrlAbstract/FREE Full Text
15. ↵
    1. Baeesa SS,
    2. Maghrabi YE,
    3. Baeesa MS,
    4. Jan FM,
    5. Jan MM

    (2017) Publications pattern of clinical epilepsy research in Saudi Arabia. Neurosciences (Riyadh) 22:255–260.

    OpenUrl
16. ↵
    1. Nair SC,
    2. Ibrahim H,
    3. Celentano DD

    (2013) Clinical trials in the Middle East and North Africa (MENA) Region:grandstanding or grandeur? Contemp Clin Trials 36:704–710.

    OpenUrlCrossRefPubMed
17. ↵
    1. Mbuagbaw L,
    2. Thabane L,
    3. Ongolo-Zogo P,
    4. Lang T

    (2011) The challenges and opportunities of conducting a clinical trial in a low resource setting:the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial. Trials 12:145.

    OpenUrlCrossRefPubMed
18. ↵
    1. Ali S,
    2. Alghamdi MA,
    3. Alzhrani JA,
    4. De Vol EB

    (2017) Magnitude and characteristics of clinical trials in the Kingdom of Saudi Arabia:A cross-sectional analysis. Contemp Clin Trials Commun 7:126–129.

    OpenUrl
19. ↵
    NRG Oncology, Available from: https://www.nrgoncology.org/. [Update:Accessed 2019 November 25].
20. The Children's Oncology Group, Available from: https://www.childrensoncologygroup.org/. [Accessed 2019 November 25].
21. ↵
    European Organisation for Research and Treatment of Cancer, Available from: https://www.eortc.org. [Accessed 2019 November 25].